These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25185654)

  • 1. Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma.
    Ma W; Zhang X; Chai J; Chen P; Ren P; Gong M
    Tumour Biol; 2014 Dec; 35(12):12467-72. PubMed ID: 25185654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
    Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y
    J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q; Song S; Ni G; Li Y; Wang X
    Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
    Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
    Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
    Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
    Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of serum miR-124 as a biomarker for diagnosis and prognosis in osteosarcoma.
    Cong C; Wang W; Tian J; Gao T; Zheng W; Zhou C
    Cancer Biomark; 2018 Feb; 21(2):449-454. PubMed ID: 29125481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of microRNA-26a-5p predicted a poor survival outcome in osteosarcoma patients: An observational study.
    Xie XY; Chen XM; Shi L; Liu JW
    Medicine (Baltimore); 2021 Mar; 100(12):e24765. PubMed ID: 33761638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
    Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC
    Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of serum miR-194 predicts poor prognosis in osteosarcoma patients.
    Shi L; Xie C; Zhu J; Chen X
    Ann Diagn Pathol; 2020 Jun; 46():151488. PubMed ID: 32172218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
    Diao ZB; Sun TX; Zong Y; Lin BC; Xia YS
    J Int Med Res; 2020 Dec; 48(12):300060520967818. PubMed ID: 33284712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma.
    Cao L; Wang J; Wang PQ
    Biomed Pharmacother; 2016 Dec; 84():828-835. PubMed ID: 27723574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma.
    Allen-Rhoades W; Kurenbekova L; Satterfield L; Parikh N; Fuja D; Shuck RL; Rainusso N; Trucco M; Barkauskas DA; Jo E; Ahern C; Hilsenbeck S; Donehower LA; Yustein JT
    Cancer Med; 2015 Jul; 4(7):977-88. PubMed ID: 25784290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.
    Xu SH; Yang YL; Han SM; Wu ZH
    World J Surg Oncol; 2014 Jun; 12():195. PubMed ID: 24969351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of circulating miR-663a as a potential biomarker for diagnosing osteosarcoma.
    Huang C; Sun Y; Ma S; Vadamootoo AS; Wang L; Jin C
    Pathol Res Pract; 2019 Jun; 215(6):152411. PubMed ID: 30987831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma.
    Pang PC; Shi XY; Huang WL; Sun K
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3765-3769. PubMed ID: 27735043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.
    Zhang C; Yao C; Li H; Wang G; He X
    Int J Clin Exp Pathol; 2014; 7(7):4194-203. PubMed ID: 25120799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
    Zhou S; Wang B; Hu J; Zhou Y; Jiang M; Wu M; Qin L; Yang X
    Tumour Biol; 2016 Jul; 37(7):9001-7. PubMed ID: 26758431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma.
    Yuan J; Chen L; Chen X; Sun W; Zhou X
    J Int Med Res; 2012; 40(6):2090-7. PubMed ID: 23321165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma.
    Tang J; Zhao H; Cai H; Wu H
    Biomed Pharmacother; 2015 Apr; 71():222-6. PubMed ID: 25960240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.